Lataa...
Brief Report: Estimating Disease Activity Using Multi‐Biomarker Disease Activity Scores in Rheumatoid Arthritis Patients Treated With Abatacept or Adalimumab
OBJECTIVE: To assess the ability of a multi‐biomarker disease activity (MBDA) test (Vectra DA) to reflect clinical measures of disease activity in patients enrolled in the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic‐Naive RA Subjects with Background Methotrexate) trial. METHODS: In the...
Tallennettuna:
| Julkaisussa: | Arthritis Rheumatol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6099512/ https://ncbi.nlm.nih.gov/pubmed/27111089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39714 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|